AZAthina Zarachi

Athina Zarachi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Athina Zarachi has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Angelos Liontos

    Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

    6 shared publications
  • Ioannis Komnos

    Department of Otorhinolaryngology, Head and Neck Surgery, School of Health Sciences, University Hospital of Ioannina, University of Ioannina, Ioannina, GRC

    3 shared publications
  • Vasileios Pezoulas

    Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, Panepistimioupoli Ioanninon, University of Ioannina, Ioannina, GRC

    3 shared publications
  • Aikaterini Lianou

    Department of Otorhinolaryngology, Head and Neck Surgery, School of Health Sciences, University Hospital of Ioannina, University of Ioannina, Ioannina, Greece

    2 shared publications
  • Aikaterini N. Lianou

    Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece, Stavros Niarchos Avenue, 451 10, Ioannina, Greece

    2 shared publications
  • Alkistis Tsikou

    Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

    2 shared publications

Latest Publications

    • 1 March 2024
      • Vol. 19  (1) , 154-159

    Solitary Fibrous Tumor of the Masticator Space with Unusual Extension: a Case Report

    by Evangelos Giotakis, Athina Zarachi, Spyridoula Derka, Georgios Pavlidis, Aikaterini Lianou, Victoria Tsoumani, Angelos Liontos, Evangelos Tsiambas, Vasileios Ragos

    Background: We present the case of a patient with solitary fibrous tumor of the masticator space with unusual extension.


  • Open Access

    Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19

    by Angelos Liontos, Dimitrios Biros, Rafail Matzaras, Konstantina-Helen Tsarapatsani, Nikolaos-Gavriel Kolios, Athina Zarachi, Konstantinos Tatsis, Christiana Pappa, Maria Nasiou, Eleni Pargana, et al.

    Background: A link between inflammation and venous thromboembolism (VTE) in COVID-19 disease has been suggested pathophysiologically and clinically. The aim of this study was to investigate the association between inflammation and disease outcomes in adult hospitalized COVID-19 patients with VTE. Methods: This was a retrospective observational study, including quantitative and qualitative data collected from COVID-19 patients hospitalized at the Infectious Diseases Unit (IDU) of the University Hospital of Ioannina, from 1 March 2020 to 31 May 2022. Venous thromboembolism was defined as a diagnosis of pulmonary embolism (PE) and/or vascular tree-in-bud in the lungs. The burden of disease, assessed by computed tomography of the lungs (CTBoD), was quantified as the percentage (%) of the affected lung parenchyma. The study outcomes were defined as death, intubation, and length of hospital stay (LoS). A chi-squared test and univariate logistic regression analyses were performed in IBM SPSS 28.0. Results: After propensity score matching, the final study cohort included 532 patients. VTE was found in 11.2% of the total population. In patients with VTE, we found that lymphocytopenia and a high neutrophil/lymphocyte ratio were associated with an increased risk of intubation and death, respectively. Similarly, CTBoD > 50% was associated with a higher risk of intubation and death in this group of patients. The triglyceride–glucose (TyG) index was also linked to worse outcomes. Conclusions: Inflammatory indices were associated with VTE. Lymphocytopenia and an increased neutrophil-to-lymphocyte ratio negatively impacted the disease’s prognosis and outcomes. Whether these indices unfavorably affect outcomes in COVID-19-associated VTE must be further evaluated.


  • The Utility of Stroboscopy in Evaluating Patients with Benign Vocal Fold Lesions

    by Athina Zarachi, Dionysios Tafiadis, Georgios Exarchakos, Aikaterini N. Lianou, Angelos Liontos, Georgios Psychogios

    Purpose: The present study aims to provide a comprehensive analysis of the use of stroboscopy as an assessment tool for patients with benign lesions of the vocal folds. Methods: The current study was based on an extensive review of the international bibliography regarding the evaluation of voice in patients with benign lesions of the vocal cords using videostroboscopy. Results: Stroboscopy is a convenient technique used by otolaryngologists that has been established as a valuable diagnostic tool for assessing patients with dysphonia and benign vocal cords lesions. Conclusions: Stroboscopy is recommended in the literature as the preferred method for assessing vocal cord vibratory function. The future poses challenges in standardizing guidelines and quantifying measurements of stroboscopic findings.


  • Open Access

    Visual Analogue Scale for the Evaluation of Olfactory and Gustatory Dysfunction of COVID-19 Patients in Northwestern Greece

    by Athina Zarachi, Aikaterini D. Lianou, Vasileios Pezoulas, Ioannis Komnos, Orestis Milionis, Dimitrios Fotiadis, Haralampos Milionis, Ioannis G. Kastanioudakis, Angelos Liontos, Ioannis G. Kastanioudakis Sr.

    Background The visual analogue scale (VAS) has been used as a diagnostic tool for the evaluation of the severity of olfactory and gustatory dysfunction (OGD) caused by SARS-CoV2 infection. The main objective of the present study was the evaluation of OGD with VAS in COVID-19-positive patients in Northwestern Greece and its possible association with the patients' self-reported symptoms of olfactory and gustatory dysfunction. Methods The presence of olfactory and gustatory symptoms and their severity were assessed by questionnaire along with the use of specific odorants and tastant ingredients, in three time periods: prior to COVID-19, during COVID-19 (initial diagnosis) and post-COVID-19 disease (at four weeks from disease onset). Three hundred COVID-19-positive patients (home-quarantined and hospitalized) tested with RT-PCR test in the University Hospital of Ioannina Greece were included in this study. Statistical analysis was performed on SPSS Statistics 26.0 (IBM Corp., Armonk, NY) Results Out of a total of 300 patients, 146 and 190 patients had mild hyposmia and hypogeusia respectively, followed by patients with severe hyposmia or hypogeusia (118 and 88 respectively), at the time of COVID-19 onset (initial diagnosis). An increase in the number of patients with recovery of symptoms was observed during the follow-up period, during which only eight patients had non-resolving severe symptoms (six patients with hyposmia and two with hypogeusia). On further analysis, a statistically significant association was found between the severity of symptoms (assessed by VAS score) and the self-reported symptoms of sensory dysfunction by the patients. There was a significant association between the groups of patients with mild hyposmia and patients that reported no loss of smell; between the patients with moderate hyposmia and the patients who reported "loss of smell"; and between the patients with severe hyposmia and the group of patients who reported a loss of smell, at the COVID-19 onset period. Similarly, patients with mild hyposmia were associated with those that reported a loss of smell at the same time. The severity of hyposmia was also associated with the reported symptom of "loss of taste" at the time of COVID-19 diagnosis. Similar findings were observed regarding the severity of hypogeusia and the reported symptom of “loss of taste” among the groups of patients. Finally, the severity of hypogeusia was associated with smell loss at the time of initial diagnosis of the infection. Conclusion Similar to the literature data, our findings indicate that hyposmia and hypogeusia are common symptoms of COVID-19 disease with varying severity. In our study, most of the patients exerted a complete recovery of these OGD symptoms. In addition, we found an association between olfactory dysfunction and self-reported sensory of taste as well as gustatory dysfunction and sensory of smell. Finally, we found that the VAS score was a reliable diagnostic tool in the estimation of OGD in this cohort of patients. However, our results need to be confirmed by larger-scale trials.


  • Treatment of Merkel Cell Carcinoma Using Intraoperative Flow Cytometry (iFC) Protocol, Optimized for Head and Neck Lesions, as a Means for Tumor Margin Evaluation – a Case Presentation

    by Athina Zarachi, Evrysthenis Vartholomatos, Alkistis Tsikou, Ioannis Komnos, Alexandra Papoudou-Bai, Evangelia Lampri, Angelos Liontos, Vasilios Ragos

    Background: We present the case of a patient with a Merkel cell carcinoma (MCC) of the left preauricular area.

  • Dizziness in the Emergency Department: Insights and Epidemiological Data – a Population Based Study

    by Athina Zarachi, Vasileios Pezoulas, Aikaterini Lianou, Alkistis Tsikou, Ilias Tsiakas, Konstantina Dinaki, Fotiadis Dimitrios, Angelos Liontos

    Background:Dizziness is a commonly referred symptom in emergency departments (EDs). The aim of this study is to describe the epidemiology of dizziness included acute vestibular syndrome (AVS) in the ED of the University Hospital of Ioannina, Grecce, during a six-month period.


  • The Impact of Age and Gender and Their Association with Chemosensory Dysfunction, in Hospitalized and Self-Quarantine Patients with Covid-19 Infection, in Epirus, Greece

    by Athina Zarachi, Vasileios Pezoulas, Orestis Milionis, Aikaterini N. Lianou, Eleutherios Klouras, Ioannis Komnos, Dimitrios Fotiadis, Ioannis Kastanioudakis, Charalampos Milionis, Angelos Liontos

    Objective:Olfactory and gustatory dysfunction that relates with the infection from severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) has already improved. The relation between chemosensory dysfunction and age and gender in covid-19 positive patients is the main objective of the present study.